Back
Synopsys, Inc. Vs. Olema Pharmaceuticals, Inc. Industry Stock Comparison
Sell
42
SNPS
Synopsys, Inc.
Last Price:
$477.37
Seasonality Move:
-2.73%
Buy
66
OLMA
Olema Pharmaceuticals, Inc.
Last Price:
$31.53
Seasonality Move:
-6.94%
Sell
42
Synopsys, Inc. (SNPS)
is a Sell
Is Synopsys, Inc. a Buy, Sell or Hold?
-
The current Synopsys, Inc. [SNPS] share price is $477.26. The Score for SNPS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
SNPS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
66
Olema Pharmaceuticals, Inc. (OLMA)
is a Buy
Is Olema Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Olema Pharmaceuticals, Inc. [OLMA] share price is $31.58. The Score for OLMA is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
OLMA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SNPS Stock Price Chart
What is Synopsys, Inc.'s stock price today?
-
The Synopsys, Inc. share price today is $477.26Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SNPS is experiencing buying pressure, which is a positive indicator for future bullish movement.
OLMA Stock Price Chart
What is Olema Pharmaceuticals, Inc.'s stock price today?
-
The Olema Pharmaceuticals, Inc. share price today is $31.58Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and OLMA is experiencing slight selling pressure.
SNPS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 12.9 | Buy |
| Relative Strength Index (14 RSI): | 70.83 | Buy |
| Chaikin Money Flow: | 2887151 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (386.46 - 454.02) | Buy |
| Bollinger Bands (100): | (415.68 - 586.36) | Sell |
OLMA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.78 | Buy |
| Relative Strength Index (14 RSI): | 81.61 | Buy |
| Chaikin Money Flow: | -458148 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.71 - 29.31) | Buy |
| Bollinger Bands (100): | (3.38 - 18.1) | Buy |
SNPS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 466.37 | Buy |
| 20-day SMA: | 426.06 | Buy |
| 50-day SMA: | 437.26 | Buy |
| 200-day SMA: | 488.29 | Sell |
| 8-day EMA: | 462.08 | Buy |
| 20-day EMA: | 442.6 | Buy |
| 50-day EMA: | 447.86 | Buy |
| 200-day EMA: | 488.27 | Sell |
OLMA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.26 | Buy |
| 20-day SMA: | 23.56 | Buy |
| 50-day SMA: | 14.96 | Buy |
| 200-day SMA: | 7.59 | Buy |
| 8-day EMA: | 28.43 | Buy |
| 20-day EMA: | 24.02 | Buy |
| 50-day EMA: | 17.44 | Buy |
| 200-day EMA: | 10.17 | Buy |
Synopsys, Inc. Earnings Growth & SNPS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, an increase next quarter of $0.53 per share, a decrease this year of $0.30 per share, and an increase next year of $1.56 per share.
Olema Pharmaceuticals, Inc. Earnings Growth & OLMA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.59 per share, and a decrease next year of $0.42 per share.
Synopsys, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Olema Pharmaceuticals, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||